Use the search parameters below to filter talks:

Calendar
Calendar

2017 - IPITA (Oxford)

Alternative Islet Sources
21 June 2017  /  11:00 - 12:30

Beta cell maturation in human stem-cell derived implants followed over one year

Presenter: Thomas Robert, Brussels, Belgium

- Beta cell maturation in human stem-cell derived implants followed over one year

Presenter: Thomas Robert, Brussels, Belgium

Ischemia response of human stem cell-derived insulin-producing cells

Presenter: GF Faleo, San Francisco, United States

- Ischemia response of human stem cell-derived insulin-producing cells

Presenter: GF Faleo, San Francisco, United States

Transdifferentiation of isolated human exocrine cells to beta like-cells.

Presenter: S Abadpour, Oslo, Norway

- Transdifferentiation of isolated human exocrine cells to beta like-cells.

Presenter: S Abadpour, Oslo, Norway

Partial Pancreatectomy Induces Beta Cell Regeneration in Cynomolgus Monkey

Presenter: DY Shin, Seoul, Korea

- Partial Pancreatectomy Induces Beta Cell Regeneration in Cynomolgus Monkey

Presenter: DY Shin, Seoul, Korea

Pairing pre-transplant islet function with recipient insulin requirements results in long-term normoglycemia in non-immunosuppressed spontaneously diabetic BB rats

Presenter: RW Holdcraft, Xenia, United States

- Pairing pre-transplant islet function with recipient insulin requirements results in long-term normoglycemia in non-immunosuppressed spontaneously diabetic BB rats

Presenter: RW Holdcraft, Xenia, United States

Gene therapy in natural canine diabetes mellitus; a potential future treatment and a new model for research in diabetes?

Presenter: R D Foale, Six Mile Bottom, United Kingdom

- Gene therapy in natural canine diabetes mellitus; a potential future treatment and a new model for research in diabetes?

Presenter: R D Foale, Six Mile Bottom, United Kingdom

Islet Biology
21 June 2017  /  11:00 - 12:30

Interleukin-22 reverses human islets dysfunction and apoptosis triggered by hyperglycemia and LIGHT

Presenter: S Abadpour, Oslo, Norway

- Interleukin-22 reverses human islets dysfunction and apoptosis triggered by hyperglycemia and LIGHT

Presenter: S Abadpour, Oslo, Norway

 HSPB1 displays a pivotal role in prolactin inhibition of ER-stress-induced beta-cell death  

Presenter: Leticia Labriola, São Paulo, Brazil

-  HSPB1 displays a pivotal role in prolactin inhibition of ER-stress-induced beta-cell death  

Presenter: Leticia Labriola, São Paulo, Brazil

Identification of Stress-specific microRNAs in Exosomes Released from Islets using Next-generation Sequencing

Presenter: Bashoo Naziruddin, Dallas, United States

- Identification of Stress-specific microRNAs in Exosomes Released from Islets using Next-generation Sequencing

Presenter: Bashoo Naziruddin, Dallas, United States

Effect of the conditioned medium of immortalized pancreatic mesenchymal stromal cells on the function of β-cells

Presenter: O Villard, MONTPELLIER, France

- Effect of the conditioned medium of immortalized pancreatic mesenchymal stromal cells on the function of β-cells

Presenter: O Villard, MONTPELLIER, France

MicroRNA-375 analysis of human islet damage during in vitro culture

Presenter: Y Shindo, Richmond, United States

- MicroRNA-375 analysis of human islet damage during in vitro culture

Presenter: Y Shindo, Richmond, United States

Human Amniotic Epithelial Cells Protect Islets from Pro-Inflammatory Cytokines

Presenter: Fanny Lebreton, , Switzerland

- Human Amniotic Epithelial Cells Protect Islets from Pro-Inflammatory Cytokines

Presenter: Fanny Lebreton, , Switzerland

In silico simulation and in vitro viability assay reveals that hypoxic core is the cause of cell death in isolated pancreatic islets.

Presenter: HK Komatsu, Duarte, United States

- In silico simulation and in vitro viability assay reveals that hypoxic core is the cause of cell death in isolated pancreatic islets.

Presenter: HK Komatsu, Duarte, United States

Young Investigator Oral Prize Session
21 June 2017  /  13:30 - 14:40

Pancreas Transplants from donors <30kg: are outcomes acceptable?

Presenter: Talal Al-Qaoud, Madison, United States

- Pancreas Transplants from donors <30kg: are outcomes acceptable?

Presenter: Talal Al-Qaoud, Madison, United States

Chemical Conjugation of a Cleavable TLR4 Antagonist to the Islet Surface is Well-Tolerated and Improves Islet Transplant Outcomes by Inhibiting NFkB-Mediated Inflammation

Presenter: Charles Chang, Dallas, United States

- Chemical Conjugation of a Cleavable TLR4 Antagonist to the Islet Surface is Well-Tolerated and Improves Islet Transplant Outcomes by Inhibiting NFkB-Mediated Inflammation

Presenter: Charles Chang, Dallas, United States

PRISM: A Fast, Compact, In-line, High Yield, Human Pancreatic Islet Isolation Method 

Presenter: Jason Doppenberg, Leiden, Netherlands

- PRISM: A Fast, Compact, In-line, High Yield, Human Pancreatic Islet Isolation Method 

Presenter: Jason Doppenberg, Leiden, Netherlands

SiRNA inhibition of tissue factor expression reduces liver ischemia after pancreatic islet transplantation in rat.

Presenter: LK Kosinova, Prague, Czech Republic

- SiRNA inhibition of tissue factor expression reduces liver ischemia after pancreatic islet transplantation in rat.

Presenter: LK Kosinova, Prague, Czech Republic

Human derived pancreatic endoderm cells reversed diabetes in mice post-transplantation into a prevascularized subcutaneous site

Presenter: AR Pepper, Edmonton, Canada

- Human derived pancreatic endoderm cells reversed diabetes in mice post-transplantation into a prevascularized subcutaneous site

Presenter: AR Pepper, Edmonton, Canada

Pancreas Transplantation - Surgical Aspects
21 June 2017  /  14:45 - 16:00

Portal Endocrine and Gastric Exocrine Drainage Technique of Pancreas Transplantation: Ten-Year Experience at a Single Center

Presenter: Hosein Shokouh-Amiri, , United States

- Portal Endocrine and Gastric Exocrine Drainage Technique of Pancreas Transplantation: Ten-Year Experience at a Single Center

Presenter: Hosein Shokouh-Amiri, , United States

Long-term outcomes of pancreas transplant recipients with partial venous thrombosis treated conservatively with anticoagulation

Presenter: GR Roll, San Francisco, United States

- Long-term outcomes of pancreas transplant recipients with partial venous thrombosis treated conservatively with anticoagulation

Presenter: GR Roll, San Francisco, United States